Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PF-07258669 by Pfizer for Malnutrition: Likelihood of Approval
PF-07258669 is under clinical development by Pfizer and currently in Phase I for Malnutrition. According to GlobalData, Phase I drugs...